INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 55 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q4 2015. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $143,000 | +155.4% | 266,588 | +265.5% | 0.00% | – |
| Q4 2017 | $56,000 | -87.1% | 72,944 | -54.6% | 0.00% | – |
| Q2 2017 | $434,000 | -21.5% | 160,740 | +22.1% | 0.00% | – |
| Q4 2016 | $553,000 | -7.1% | 131,610 | +50.3% | 0.00% | – |
| Q3 2016 | $595,000 | -11.5% | 87,568 | -24.6% | 0.00% | – |
| Q2 2016 | $672,000 | -47.9% | 116,190 | -37.2% | 0.00% | – |
| Q1 2016 | $1,291,000 | +195.4% | 185,010 | +205.4% | 0.00% | – |
| Q4 2015 | $437,000 | -74.4% | 60,581 | -69.4% | 0.00% | – |
| Q3 2015 | $1,704,000 | +18.5% | 197,756 | +122.0% | 0.00% | – |
| Q2 2015 | $1,438,000 | – | 89,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|